GULLKNAPP PHARMA AS
Operating
Kjøp og salg av helse- og kroppspleieprodukter og bøker, import og
eksport samt delta i annen virksomhet ved tegning av aksjer eller på
annen måte samt annet som naturlig hører herunder. Selskapet har også
som formål å investere i kunst.
Kjøp og salg av bøker, helse- og kroppspleieprodukter, import og
eksport av helse- og kroppspleieprodukter og deltagelse i andre
selskaper og hva som står i forbindelse med dette.
Organization
- CEO
- JT
- Chairman of the board
- JT
- Years since formation
- 21 years
- since Jul 13, 2005
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 2 share classes
- Total number of shareholders
- 2
- persons
Financials
- Total operating income 2025
- 2,557,351
- NOK
- Annual total result 2025
- -185,961
- NOK
- Total equity 2025
- 1,603,857
- NOK
Last update: Aug 3, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JT | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
JT | Chairman | - |
| Alternate Member | 100 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| Alternate Member | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Class B shares | 700 | 70 % | |
| A-shares | 300 | 30 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,557,351 | 3,545,659 | 3,893,049 | 3,796,501 | 4,382,416 |
Annual Total Result | -185,961 | 27,308 | -781,723 | -1,041,533 | -255,678 |
Total assets | 4,401,744 | 5,229,470 | 5,069,322 | 4,019,276 | 4,926,508 |
Total liabilities | 2,797,887 | 3,439,652 | 3,306,812 | 1,475,042 | 1,340,741 |
Total equity | 1,603,857 | 1,789,818 | 1,762,510 | 2,544,233 | 3,585,767 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,557,351 | 3,545,659 | 3,893,049 | 3,796,501 | 4,382,416 |
Total operating costs | 2,733,370 | 3,516,730 | 4,644,100 | 4,766,783 | 4,713,885 |
Operating result | -176,019 | 28,928 | -751,050 | -970,282 | -331,468 |
Financial income/costs | -9,941 | -1,621 | -30,673 | 32 | 4,508 |
Profit before tax | -185,961 | 27,308 | -781,723 | -970,250 | -326,961 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 71,283 | -71,283 |
Annual Total Result | -185,961 | 27,308 | -781,723 | -1,041,533 | -255,678 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 2,758,359 | 2,683,533 | 10,570 | 23,253 | 107,219 |
Total current assets | 1,643,385 | 2,545,937 | 5,058,752 | 3,996,023 | 4,819,289 |
Total assets | 4,401,744 | 5,229,470 | 5,069,322 | 4,019,276 | 4,926,508 |
Short term debt | 2,797,887 | 3,439,652 | 3,306,812 | 1,475,042 | 1,340,741 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 2,797,887 | 3,439,652 | 3,306,812 | 1,475,042 | 1,340,741 |
Contributed capital | 100,450 | 100,450 | 100,450 | 100,450 | 100,450 |
Retained earnings | 1,503,407 | 1,689,368 | 1,662,060 | 2,443,783 | 3,485,317 |
Total equity | 1,603,857 | 1,789,818 | 1,762,510 | 2,544,233 | 3,585,767 |
Total equity and liabilities | 4,401,744 | 5,229,470 | 5,069,322 | 4,019,275 | 4,926,508 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification